Portola: PTLA file $115m IPOYou have any potential interest in this one? Looks like Dew is fairly skeptical on the lead drug in P3, betrixaban, and the related product in Phase 2 (PRT4445). Do you feel the same? I think the dual JAK/Syk inhibitor for heme onc (B-cell) could be interesting: http://www.portola.com/Product-Pipeline . I'm curious to find out what fully-diluted market cap will be for this one when it starts trading.
Market Data 
Markets 
AI
